Request for Quotation (RFQ) for the provision of digital adherence technology and cloud-based platform for clinical trial participants

Background: KNCV Tuberculosis Foundation

KNCV Tuberculosis Foundation (KNCV) is an international non-profit organization dedicated to the fight against tuberculosis (TB), still the second most deadly infectious disease in the world. KNCV is an international center of expertise for TB control that promotes effective, efficient, innovative and sustainable TB control strategies in a national and international context. We are an organization of passionate TB professionals, including doctors, researchers, training experts, nurses and epidemiologists. We aim to stop the spread of the worldwide epidemic of TB and to prevent the further spread of drug-resistant TB.

Background: The Unite4TB project

The UNITE4TB project, that started in 2021, aims to set a new standard for anti-TB regimen development. It will upgrade current clinical trial methodology and enhance the efficiency with which new regimens are delivered. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101007873. Throughout the trials that will be performed in the UNITE4TB project, a digital adherence technology (DAT) will be provided to participants to measure and ensure maximal adherence.

The first participant enrollment is expected in the first quarter of 2023. The trials will be conducted in 25 different trial sites across four regions; Europe, Africa, Asia, and South America. Around 2000 participants will enroll in the trial.

Objective of RFQ

To identify a supplier that can provide a digital adherence technology solution linked to a cloud-based platform to store and analyze adherence data, accepted in a regulatory trial environment (CE-IVD approved), for 2000 participants for use across 25 different trial sites.

Timeline

First contractual period will be from 1st of December 2022 to 31st of December 2024 with the possibility to extent. The total project duration will be until December 2027. The candidate should be capable to start activities within one (1) month after contract signing.

Submission

Proposals should be submitted to natalia.andreeva@kncvtbc.org and received by 11:59 CET on Sunday 16th of October 2022. Proposals received after this date and time shall be invalid and will be blocked from review. Proposals should be submitted in English and each interested party shall submit only one quotation. The quotation needs to include the following documents:

  1. Completed Requirements document
  2. Completed Budget

Selection

Selection of the candidate(s) will be based upon independent assessment of the proposals by a review committee. All quotations will be reviewed based on the following criteria:

  1. Overall suitability: proposed solutions must meet the scope and be presented in a clear and organized manner.
  2. Organizational experience: Organizations will be evaluated on their experience related to the scope of this RFQ.
  3. Value and cost: Organizations will be evaluated on the cost of their solution(s) based on the work to be performed in accordance with the scope of this project.

Questions and contact

KNCV reserves the right to request further information during the RFQ process. Questions regarding requirements described in this RFQ must be directed in writing via email to natalia.andreeva@kncvtbc.org before Friday 7th of October 2022.

Responses to questions and/or clarifications originating from such questions that improve the quality of the RFQ will be published on the same website. Issuance of a quotation does not in any way constitute a commitment on the part of KNCV nor does it commit to pay for costs incurred in the preparation and submission of proposal.

Download PDF here.

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.